Related references
Note: Only part of the references are listed.Association between high-sensitivity C-reactive protein and risk of early idiopathic Parkinson's disease
In-Uk Song et al.
NEUROLOGICAL SCIENCES (2011)
Glial reactions in Parkinson's disease
Patrick L. McGeer et al.
MOVEMENT DISORDERS (2008)
Disease-modifying drugs and Parkinson's disease
Herve Allain et al.
PROGRESS IN NEUROBIOLOGY (2008)
Drug therapy for Parkinson's disease
Neal Hermanowicz
SEMINARS IN NEUROLOGY (2007)
The role of junctional adhesion molecules in vascular inflammation
Christian Weber et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Role of ICAM-1 in persisting inflammation in Parkinson disease and MPTP monkeys
J Miklossy et al.
EXPERIMENTAL NEUROLOGY (2006)
Oxidative stress and inflammation in Parkinson's disease: Is there a causal link?
A Hald et al.
EXPERIMENTAL NEUROLOGY (2005)
Treatment of Parkinson's disease - What's on the horizon?
SS Wu et al.
CNS DRUGS (2005)
Biomarkers of vascular disease linking inflammation to endothelial activation - Part II
PE Szmitko et al.
CIRCULATION (2003)
Neuroinflammatory processes in Parkinson's disease
S Hunot et al.
ANNALS OF NEUROLOGY (2003)
Oxidized low-density lipoprotein-induced apoptosis
R Salvayre et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2002)
An inflammatory review of Parkinson's disease
CF Orr et al.
PROGRESS IN NEUROBIOLOGY (2002)
Phenolic antioxidants attenuate neuronal cell death following uptake of oxidized low-density lipoprotein
H Schroeter et al.
FREE RADICAL BIOLOGY AND MEDICINE (2000)
Share Paper
